Chang Gung Memorial Hospital has advanced cancer treatment through DC-CIK immunotherapy and CAR-T cell therapy.

Chang Gung Memorial Hospital in Taiwan has pioneered cellular therapy for cancer since 2018, establishing a state-of-the-art lab for clinical trials in immune cells and regenerative medicine. Notable advancements include DC-CIK immunotherapy, which has shown a 70-80% disease control rate in liver cancer, and CAR-T cell therapy, effective for acute lymphoblastic leukemia and diffuse large B-cell lymphoma. These innovations are reshaping cancer treatment, improving effectiveness and patient quality of life.

October 21, 2024
6 Articles